Market Place
Sourcing Support
Genetic Technologies Expands Capacity In North America
18 Jun 2024 //
GLOBENEWSWIRE
Syncona Portfolio Company Successfully Completes Tender Offer and Acquisition
01 Dec 2022 //
GLOBENEWSWIRE
Syncona Portfolio Company Extends Tender Offer to Acquire Applied Genetic
29 Nov 2022 //
GLOBENEWSWIRE
*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November
22 Nov 2022 //
GLOBENEWSWIRE
Applied Genetic Technologies Corporation Urges Shareholders to Tender
14 Nov 2022 //
GLOBENEWSWIRE
Applied Genetic Technologies Corporation Reminds Shareholders to Tender
03 Nov 2022 //
GLOBENEWSWIRE
String of gene therapy deals spurs cautious optimism on Wall Street
01 Nov 2022 //
BIOPHARMADIVE
Genetic Techn Announces Q1 FY23 Quarterly Results and Investor Webinar Details
25 Oct 2022 //
GLOBENEWSWIRE
Syncona looks to buy gene therapy biotech for $23.5M upfront
25 Oct 2022 //
FIERCE BIOTECH
Genetic Technologies Provides Update on US Operations and Payer Engagement
02 Sep 2022 //
GLOBENEWSWIRE
AGTC to Participate in Upcoming Investor Conferences
01 Aug 2022 //
GLOBENEWSWIRE
AGTC Receives Positive Type C Meeting Feedback from FDA
26 Jul 2022 //
GLOBENEWSWIRE
AGTC Announces Proposed Underwritten Public Offering
12 Jul 2022 //
GLOBENEWSWIRE
AGTC Announces Pricing of $10 Million Underwritten Public Offering
12 Jul 2022 //
GLOBENEWSWIRE
AGTC Announces Key Appointments to Leadership Team
08 Jun 2022 //
GLOBENEWSWIRE
AGTC to Present Three-Month Interim Results from the SKYLINE Trial of AGTC-501
06 Jun 2022 //
GLOBENEWSWIRE
AGTC Announces Age-Related Macular Degeneration Scientific Advisory Board
01 Jun 2022 //
GLOBENEWSWIRE
AGTC to Present at the H.C. Wainwright Global Investment Conference
18 May 2022 //
GLOBENEWSWIRE
AGTC Announces Positive 3 Month Interim Results from Skyline Trial of AGTC-501
16 May 2022 //
GLOBENEWSWIRE
AGTC Hosts Topping Off Ceremony for Gene Therapy Manufacturing Facility
10 May 2022 //
GLOBENEWSWIRE
AGTC to Present Preclinical Research Supporting Gene Therapy Platform at ASGCT
02 May 2022 //
GLOBENEWSWIRE
AGTC to Present at Cell & Gene Meeting on the Mediterranean
14 Apr 2022 //
GLOBENEWSWIRE
AGTC to Showcase Interim Findings fromXLRP, Achromatopsia Phase 1/2 Trials
04 Apr 2022 //
GLOBENEWSWIRE
AGTC Announces Pricing of Public Offering of Common Stock
22 Mar 2022 //
GLOBENEWSWIRE
AGTC Announces Proposed Public Offering of Common Stock
21 Mar 2022 //
GLOBENEWSWIRE
AGTC to Participate in Upcoming Investor Conferences
08 Mar 2022 //
GLOBENEWSWIRE
AGTC Exceeds Enrollment Target in SKYLINE Trial of AGTC-501 for XLRP
11 Jan 2022 //
GLOBENEWSWIRE
AGTC to Participate in the H.C. Wainwright BioConnect 2022 Conference
04 Jan 2022 //
GLOBENEWSWIRE
AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501
12 Nov 2021 //
GLOBENEWSWIRE
AGTC Appoints Hope D’Oyley-Gay as General Counsel
11 Nov 2021 //
GLOBENEWSWIRE
AGTC to Participate in the Stifel 2021 Virtual Healthcare Conference
10 Nov 2021 //
GLOBENEWSWIRE
AGTC to Present at Upcoming Dry AMD Therapeutic Development Summit
19 Oct 2021 //
GLOBENEWSWIRE
AGTC Announces Two Key Leadership Team Appointments
14 Oct 2021 //
GLOBENEWSWIRE
AGTC Clinical Trial Investigators to Present Data from Ongoing XLRP
28 Sep 2021 //
GLOBENEWSWIRE
AGTC to Present at the 2021 Cantor Fitzgerald Virtual GHC
27 Sep 2021 //
GLOBENEWSWIRE
Kids suffer serious adverse reactions in AGTC gene therapy trial
25 Sep 2021 //
FIERCEBIOTECH
AGTC to Host Fourth Quarter and 2021 Fiscal Year End Financial Results
16 Sep 2021 //
GLOBENEWSWIRE
AGTC Announces Jonathan I. Lieber as their new Chief Financial Officer
08 Sep 2021 //
GLOBENEWSWIRE
AGTC Appoints Industry R&D Veteran Yehia Hashad, MD to its Board of Directors
18 Aug 2021 //
GLOBENEWSWIRE
AGTC to Host Virtual R&D Day on July 22, 2021
08 Jul 2021 //
GLOBENEWSWIRE
AGTC Reports 12-Month Data from its Ongoing Ph1/2 Achromatopsia Clinical Trials
24 Jun 2021 //
GLOBENEWSWIRE
AGTC to Host Conference Call to Discuss Data in its Ongoing CNGB3 & CNGA3 Trials
23 Jun 2021 //
GLOBENEWSWIRE
AGTC Announces Publication of Preclinical Data that Support the Ongoing Develop
24 Aug 2020 //
GLOBENEWSWIRE
AGTC updates plan for retinitis pigmentosa gene therapy trials
23 Jul 2020 //
HEALIO
AGTC updates plan for retinitis pigmentosa gene therapy trials
22 Jul 2020 //
HEALIO
